Tao Sun

21PUBLICATIONS
46CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsGenome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 07, 2026
N-Myristoylation: A Central Hub Integrating Tumor Signaling, Metabolism, and Immunity for Precision Therapy.

|Aug 12, 2026
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.

|May 21, 2026
Microbial reprogramming of immunogenic cell death: a new paradigm in tumor immunotherapy.

|Mar 17, 2026
Role of BARX1 in Development and Disease.

Yiwen Ma, Xiaorui Li, Liping Xiao

|Feb 06, 2026
Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial.

Pin Zhang, Tao Sun, Ying Wang

|Feb 01, 2026
The safety of trastuzumab deruxtecan (T-DXd) in breast cancer brain metastases with a focus on interstitial lung disease/pneumonitis: A systematic review and meta-analysis.

Yiwen Ma, Xiaorui Li, Yujun Jiang

Pageof 4

Frequent Collaborators

4 joint publications

Xiaojia Wang

3 joint publications

Shusen Wang

2 joint publications

Junnan Xu

2 joint publications

Shulan Sun